“showed a trend”

Other Th2-associated cytokines, notably IL-13, showed a trend toward elevation in allergic patients (10.52 pg/mL vs. 4.37 pg/mL, p = 0.09), though did not reach statistical significance.

A significant interaction between valence and evaluation time ( F (1,252) = 4.46, p = 0.036) showed that ratings for later positively and negatively paired Fribbles did not differ at baseline ( p = 0.229), but showed a trend towards a more positive evaluation of positively paired Fribbles compared with negatively paired Fribbles ( p = 0.09, p corr = 0.364) at the delayed rating.

The GRR test showed a trend for an excess of the C-allele-containing genotype in RA index cases compared with controls (90 RA index cases versus 79 controls, P = 0.09) but not for the C/C genotype (Table 5 ).

Post hoc analysis using Newman-Keuls test showed that diazepam at the dose of 1 mg/kg showed a trend of decreased Factor1 scores compared to the vehicle group in the 0.8 mA conditioned females (p = 0.09).

Regarding length of ICU stay, pooled analysis of 12 studies showed a trend toward reduction in the melatonin group compared with controls (MD -0.45 days, 95% CI -1.10 to 0.20, P = 0.09, I 2 = 68%, Figure 7B ), although this did not reach statistical significance.

Putative parasitic nematodes showed a trend toward higher relative abundance in wilted root zones, particularly Pratylenchus crenatus , Xiphinema rivesi , and Xiphinema macroacanthum ( p = 0.09).

Echocardiographic parameters While LV ejection fraction showed a trend towards non-significant improvement after LBBP and HBP (58.3 ± 5.8% to 60.3 ± 4.9%, p = 0.09; 59.3 ± 6.4% to 61.5 ± 3.8%, p = 0.08, respectively), RVP group showed a non-significant reduction (61.2 ± 4% to 58.7 ± 8.2%, p= 0.08) during follow-up.

Pregnancy Nutritional Interventions Fish-oil supplementation in pregnancy was associated with lower total costs during the first three years of life (standardized total costs: GMR = 0.89 95% CI = (0.80; 0.98), p = 0.021) and showed a trend of association with lower direct costs (GMR = 0.88 (0.76; 1.02), p = 0.09) and number of days absent from daycare (OR = 0.90 (0.80; 1.01), p = 0.07).

None of the differences between these groups reached statistical significance, although patients who underwent labral debridement alone showed a trend toward increased OA progression ( P = .09).

Treatment with large endografts showed a trend toward a higher RT (ΔRT, 0.14 ± 0.06 second vs 0.01 ± 0.03 second; P = .09).

Patients were also stratified using TIR, with largely similar findings.Participants with eGDR <8mg/kg -1 .min -1 showed a trend towards higher mean basal PS expression, but not P-selectin, compared with higher eGDR (PS 1216±1152 vs 458±163, p=0.09 ) .

In addition, although it did not reach statistical significance, estimated apoB showed a trend towards better prediction of a future MCVE compared with LDL cholesterol (3.2% (−0.3–6.4), P = 0.09).

The correlation between CDI score and TCH in the stratified groups showed a trend towards a negative correlation in the group with TCH < 4.0 ( r = −0.216, p = 0.09) and a trend towards a positive correlation in the group with TCH > 4.0 ( r = 0.315, p = 0.076), whereas 44% of patients with MADD were in the group with TCH < 4.0 and 56% of patients with MADD in the group with TCH > 4.0. 3.2.

Ex vivo drug treatment results for the anti-CD38 antibody that were obtained clinically showed a trend toward a significant correlation with the re-treatment clinical response ( R = 0.59; P = .09; Figure 4 B) despite cell number limitations preventing analysis of the other drugs the patients received in their treatment combinations.

Partial correlations with age, gender, years of education and DZNE site as covariate showed a trend-level correlation of free recall with CSF total-tau ( R = −0.142; P = 0.090) and no correlation with phospho-tau ( R = −0.096; P = 0.250) in amyloid-negative individuals.

Concerning the history of self-mutilation, the relation with PTSD diagnosis showed a trend ( p = 0.09). 98.4 % of BPD patients with PTSD self-mutilated compared to 92.7 % of BPD patients without PTSD.

Stage IV disease was independently associated with worse survival (adjusted HR, 2.18; 95% CI, 1.20–3.95; p = 0.01), whereas RECIST PD showed a trend toward poorer survival (adjusted HR, 1.62; 95% CI, 0.92–2.84; p = 0.09) (Online Resource S4 ).

In quadriceps, chymotrypsin-like activity was significantly increased in CHF compared with sham by 79% ( P < 0.05; Figure 5 A), whereas trypsin-like activity only showed a trend towards increased activity in CHF animals by 48% ( P = 0.09; Figure 5 C).

14%; p = 0.016) and showed a trend toward reduced nasogastric tube aspiration (10% vs. 23%; p = 0.09).

In females, LF-fed WT mice show intact memory ( p < 0.001), while HF-fed WT females only showed a trend toward preference for the novel object ( p = 0.09).

1.0 ( p = 0.004), where-as LApre-systole volume showed a trend with HR 1.15 ( p = 0.09).

The Kaplan-Meier analysis showed a trend of higher all-cause mortality ( Figure 2A ) in the pVHD group, as compared to the pCHD group (P=0.09).

On multivariable analysis, none of the variables was significant, with platelets count at last follow up showed a trend towards statistical significance (OR 0.95; CI 0.90–1.00; P = .09) (Table S7, http://links.lww.com/MD/H621 ). 4.

A multivariate ANOVA between control subjects and ADHD patients under either drug condition showed a trend for a significant group effect [ F (8,62) = 2, p < .09] due to a significant univariate group effect in the standard deviation to go trials [ F (2,34) = 5, p < .02], which were higher in patients under either medication condition compared with control subjects ( p < .05).

Two-way mixed design ANOVA models showed a trend towards a significant interaction in the maximum power of the 30 s rowing test (F = 3.259, p = 0.090), while no significant interaction in other outcomes of the rowing test was observed (i.e., the average power (F = 0.571, p = 0.461), the distance (F = 0.330, p = 0.573), and the predicted time of rowing 500 m (F = 0.272, p = 0.609)) ( Table 2 ).